Early treatment of pediatric Crohn's disease with anti-tumor necrosis factor medications can substantially reduce the risk of ...

If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, ...

June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...

Nutrients specific to the Mediterranean diet could help with symptom management in inflammatory bowel disease, evidence ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

The drug is already approved in the EU to treat ulcerative colitis, another form of inflammatory bowel disease ...

A Surrey music teacher says she is determined to "rewrite the story" of her recent Christmases after spending the past three ...

Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...

If you recently learned that you have Crohn’s disease, you’re not alone. According to the National Institutes of Health, roughly 1 million people in the United States are living with this ...

A study from University of Michigan researchers may provide an explanation for why some patients with Crohn's disease continue to experience symptoms ...

ORLANDO -- A considerable amount of variability exists in surgical management of ileosigmoid fistulas in Crohn's disease (CD) ...

As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...